No name

This is the Office of the Secretary of Commerce.

mproves the health of American women by advancing a comprehensive women’s health agenda throughout HHS.

The Official Congressional Directory (also known as Congressional Directory) is the official directory of the United States Congress, prepared by the Joint Committee on Printing (JCP) and published by the United States Government Publishing Office (GPO) since 1888.

It presents short biographies of each member of the Senate and House, listed by state or district, and additional data, such as committee memberships, terms of service, administrative assistants and/or secretaries, and room numbers. Also includes maps of Congressional districts, a directory of officials of executive agencies, addresses, telephone and fax numbers, website addresses, and other information. In addition, it lists officials of the Federal Judiciary, military establishments, and other Federal departments and agencies, including D.C. government officials, governors of states and territories, foreign diplomats, and members of the press, radio, and television galleries.

Per federal statute (44 USC 721) the Directory is published and distributed during the first session of each new Congress. It is a designated essential title distributed to Federal depository libraries and the current edition is available for purchase from GPO.

2709 items
Page 79 of 113
Vol 36 Issue 15; Federal Communications Commission Record
Title:
Vol 36 Issue 15; Federal Communications Commission Record

Vol 36 Issue 15; Federal Communications Commission Record

V.30 #1 Spring 2022; The Combat Edge (formerly Tac Attack)
Title:
V.30 #1 Spring 2022; The Combat Edge (formerly Tac Attack)

V.30 #1 Spring 2022; The Combat Edge (formerly Tac Attack)

Spring 2022; The Mobility Forum
Title:
Spring 2022; The Mobility Forum

Spring 2022; The Mobility Forum

Bound Congressional Record Volume 162 Part 6
Title:
Bound Congressional Record Volume 162 Part 6

Bound Congressional Record Volume 162 Part 6

Bound Congressional Record Volume 162 Part 7
Title:
Bound Congressional Record Volume 162 Part 7

Bound Congressional Record Volume 162 Part 7

Bound Congressional Record Volume 162 Part 8
Title:
Bound Congressional Record Volume 162 Part 8

Bound Congressional Record Volume 162 Part 8

Astronomical Phenomena For The Year 2024
Title:
Astronomical Phenomena For The Year 2024

Astronomical Phenomena For The Year 2024

20-637; 2021 Supreme Court The Individual Slip Opinions Term Of Court
Title:
20-637; 2021 Supreme Court The Individual Slip Opinions Term Of Court

20-637; 2021 Supreme Court The Individual Slip Opinions Term Of Court

V.51 #4 Winter 2021-22; Parameters
Title:
V.51 #4 Winter 2021-22; Parameters

V.51 #4 Winter 2021-22; Parameters

Bound Congressional Record Volume 162 Part 9
Title:
Bound Congressional Record Volume 162 Part 9

Bound Congressional Record Volume 162 Part 9

#21-463; 2021 Supreme Court The Individual Slip Opinions Term Of Court
Title:
#21-463; 2021 Supreme Court The Individual Slip Opinions Term Of Court

#21-463; 2021 Supreme Court The Individual Slip Opinions Term Of Court

V.576 Pt.1; Official Report Of The U.s. Supreme Court Preliminary Reports 2014
Title:
V.576 Pt.1; Official Report Of The U.S. Supreme Court Preliminary Reports 2014

V.576 Pt.1; Official Report Of The U.s. Supreme Court Preliminary Reports 2014

#21-588; 2021 Supreme Court The Individual Slip Opinions Term Of Court
Title:
#21-588; 2021 Supreme Court The Individual Slip Opinions Term Of Court

#21-588; 2021 Supreme Court The Individual Slip Opinions Term Of Court

V.576 Pt.2; Official Report Of The U.s. Supreme Court Preliminary Reports 2014
Title:
V.576 Pt.2; Official Report Of The U.s. Supreme Court Preliminary Reports 2014

V.576 Pt.2; Official Report Of The U.s. Supreme Court Preliminary Reports 2014

20-480; 2021 Supreme Court The Individual Slip Opinions Term Of Court
Title:
20-480; 2021 Supreme Court The Individual Slip Opinions Term Of Court

20-480; 2021 Supreme Court The Individual Slip Opinions Term Of Court

V.577 Pt.2; Official Report Of The U.s. Supreme Court Preliminary Reports 2015
Title:
V.577 Pt.2; Official Report Of The U.s. Supreme Court Preliminary Reports 2015

V.577 Pt.2; Official Report Of The U.s. Supreme Court Preliminary Reports 2015

21a240 & 21a241; 2021 Supreme Court The Individual Slip Opinions Term Of Court
Title:
21a240 & 21a241; 2021 Supreme Court The Individual Slip Opinions Term Of Court

21a240 & 21a241; 2021 Supreme Court The Individual Slip Opinions Term Of Court

V.578 Pt.1; Official Report Of The U.s. Supreme Court Preliminary Reports 2015
Title:
V.578 Pt.1; Official Report Of The U.s. Supreme Court Preliminary Reports 2015

V.578 Pt.1; Official Report Of The U.s. Supreme Court Preliminary Reports 2015

21a244 & 21a247; 2021 Supreme Court The Individual Slip Opinions Term Of Court
Title:
21a244 & 21a247; 2021 Supreme Court The Individual Slip Opinions Term Of Court

21a244 & 21a247; 2021 Supreme Court The Individual Slip Opinions Term Of Court

V.578 Pt.2; Official Report Of The U.s. Supreme Court Preliminary Reports 2015
Title:
V.578 Pt.2; Official Report Of The U.s. Supreme Court Preliminary Reports 2015

V.578 Pt.2; Official Report Of The U.s. Supreme Court Preliminary Reports 2015

19-1401; 2021 Supreme Court The Individual Slip Opinions Term Of Court
Title:
19-1401; 2021 Supreme Court The Individual Slip Opinions Term Of Court

19-1401; 2021 Supreme Court The Individual Slip Opinions Term Of Court

V.579 Pt.1; Official Report Of The U.s. Supreme Court Preliminary Reports 2015
Title:
V.579 Pt.1; Official Report Of The U.s. Supreme Court Preliminary Reports 2015

V.579 Pt.1; Official Report Of The U.s. Supreme Court Preliminary Reports 2015

#143 Orig.; 2021 Supreme Court The Individual Slip Opinions Term Of Court
Title:
#143 Orig.; 2021 Supreme Court The Individual Slip Opinions Term Of Court

#143 Orig.; 2021 Supreme Court The Individual Slip Opinions Term Of Court

Approved Drug Products With Therapeutic Equivalence 42nd Edition 2022
Title:
Approved Drug Products With Therapeutic Equivalence 42nd Edition 2022

Approved Drug Products With Therapeutic Equivalence 42nd Edition 2022

Back to Top